+218.1%
MRNA vs ALLY
+65.3%
+152.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALLY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.8% | -4.3% | -3.8% |
| 7D | -12.1% | +0.4% | -12.5% | -12.2% |
| 30D | -1.3% | +5.2% | -6.5% | -3.5% |
| 3M | +250.9% | -13.3% | +264.2% | +274.0% |
| 6M | +343.0% | -6.7% | +349.7% | +354.5% |
| YTD | +657.4% | -12.8% | +670.3% | +701.2% |
| 1Y | +794.9% | +0.7% | +794.2% | +780.3% |
| 3Y | +218.1% | +65.2% | +152.9% | +159.4% |
| All | +218.1% | +65.3% | +152.8% | +159.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLY.
Daily Out/Under-Performance
Portfolio return minus ALLY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALLY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling